Icariin induces mouse embryonic stem cell differentiation into beating functional cardiomyocytes

Area of Science:

• Cardiovascular Research
• Stem Cell Biology
• Pharmacology

Background:

• Icariin, derived from Epimedium extracts, is known to induce cardiomyocyte differentiation in murine embryonic stem (mES) cells.
• Previous studies lacked functional characterization of these icariin-induced cardiomyocytes, limiting their clinical application potential.

Purpose of the Study:

• To structurally and functionally characterize cardiomyocytes derived from mES cells treated with icariin.
• To evaluate the potential of these cells for transplantation in treating cardiac failure.

Main Methods:

• mES cells were differentiated into embryoid bodies (EBs) using a direct suspension method with icariin.
• Protein expression (immunofluorescence) and ultrastructure (transmission electron microscopy) were analyzed.
• Cardiac-specific and calcium-handling gene expression (RT-PCR) was quantified.

Main Results:

• Icariin-induced cardiomyocytes expressed key cardiac proteins: myosin light chain-1v (MLC1v), atrial natriuretic polypeptide (ANP), and cardiac troponin I (cTnI).
• Ultrastructural analysis revealed organized myofibrils with mature sarcomeres (A and I bands).
• mRNA levels of MLC1v, ANP, cTnI, calsequestrin (CSQ), and sodium-calcium exchanger (NCX) were significantly upregulated.

Conclusions:

• Icariin effectively induces differentiation of mES cells into beating cardiomyocytes with normal structure and function.
• These findings highlight the promising therapeutic potential of icariin-induced cardiomyocytes in cardiac cell therapy and tissue engineering.